When Substance Use Is Underreported: Comparing Self-Reports and Hair Toxicology in an Urban Cohort of Young Adults - 27/06/23

Abstract |
Objective |
Large-scale epidemiological research often uses self-reports to determine the prevalence of illicit substance use. Self-reports may suffer from inaccurate reporting but can be verified with objective measures. This study examined the following: the prevalence of illicit and non-medical substance use with self-reports and hair toxicology, the convergence of self-reported and objectively quantified substance use, and the correlates of under- and overreporting.
Method |
The data came from a large urban cohort study of young adults (n = 1,002, mean age = 20.6 years, 50% female). The participants provided 3 cm of hair (covering the previous 3 months) and reported their illicit and non-medical substance use and their sociodemographic, psychological, and behavioral characteristics. Hair toxicology analyses targeted cannabinoids, ketamine, opiates/opioids, stimulants including 3,4-methylenedioxymethamphetamine, and relevant metabolites.
Results |
Self-reports underestimated the prevalence of most substances by 30% to 60% compared to hair tests. The average detection ratio (hair test/self-report) was 1.50. Hair tests were typically more sensitive than self-reports. Underreporting was associated with a low level of that substance in hair. Self-reported delinquency and psychopathology were correlated with an increased likelihood of concordant positive self-reports and hair tests compared to underreporting. Overreporting was associated with infrequent self-reported use.
Conclusion |
Our study suggests that self-reports underestimate young adults’ exposure to illicit substances and non-medical use of prescription drugs. Consequently, estimates of associations between substance use and risk factors or outcomes are likely biased. Combining self-reports with hair tests may be most beneficial in study samples with occasional substance use. Researchers can use specific factors (eg, detection ratios) to adjust prevalence estimates and correlations based on self-reports.
Le texte complet de cet article est disponible en PDF.Key words : substance use, non-medical use of prescription drugs, hair toxicology, prevalence, young adults
Plan
| Drs. Steinhoff and Quednow contributed equally to this work. |
|
| The Swiss National Science Foundation funded this analysis (SNF; Grant #10531C_189008 [Lilly Shanahan and Boris B. Quednow]. The Jacobs Center and the SNF supported our larger research (#10FI14_170409 [Michael Shanahan]; #10FI14_198052 [Denis Ribeaud and Lilly Shanahan]. Started by Manuel Eisner and Denis Ribeaud, the Zurich Project on Social Development from Childhood to Adulthood had phases from 2003–2024 funded by SNF, Jacobs Foundation, Swiss Federal Office of Public Health, Department of Education of the Canton of Zurich, and Swiss State Secretariat of Migration and its predecessors, Julius Bär Foundation, and Visana Plus Foundation. |
|
| The research was performed with permission from Cantonal Ethics Committee Zurich and the Ethics Committee of the Faculty of Arts and Social Sciences, University of Zurich. |
|
| Author Contributions Conceptualization: Steinhoff, Shanahan, Quednow Data curation: Steinhoff, Bechtiger, Zimmermann, Ribeaud, Eisner, Baumgartner Formal analysis: Steinhoff, Bechtiger Funding acquisition: Shanahan, Ribeaud, Eisner, Quednow Investigation: Shanahan, Ribeaud, Eisner, Baumgartner, Quednow Methodology: Steinhoff, Shanahan, Bechtiger, Baumgartner, Quednow Project administration: Shanahan, Quednow Visualization: Steinhoff Writing – original draft: Steinhoff, Shanahan, Quednow Writing – review and editing: Steinhoff, Shanahan, Bechtiger, Zimmermann, Ribeaud, Eisner, Baumgartner, Quednow |
|
| The authors thank all the participants and the field managers of z-proso, who assisted with the data collection and cared for the study participants. |
|
| Disclosure: Drs. Steinhoff, Shanahan, Ribeaud, Eisner, Baumgartner, and Quednow, Ms. Bechtiger, and Mr. Zimmermann have reported no biomedical financial interests or potential conflicts of interest. |
Vol 62 - N° 7
P. 791-804 - juillet 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
